|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
05.04.2024, 08.08.2024
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
With our announcement dated 5 April 2024, it was disclosed that a Share Purchase Agreement was signed for the acquisition of our 50% share in Eczacıbaşı Monrol Nuclear Products Industry and Trade Inc. by Curium International Trading B.V. In the announcement dated 8 August 2024, it was further disclosed that, following the assessments regarding the Turkish Competition Authority's approval, which is among the preconditions for the transaction, the relevant transaction was decided to be subject to a final review in accordance with Article 10, Paragraph 1 of Law No. 4054 on the Protection of Competition, and the process is ongoing by
the Turkish Competition Authority.
It has now been understood that the final review conducted by the Turkish Competition Authority will not be completed by 27 January 27 2025, the end of its six-month period. Accordingly, it has been communicated to our company that, pursuant to Article 43 of Law No. 4054 on the Protection of Competition, the final review period will be extended by six months starting from 27 January 2025. In this context, the process is ongoing, and developments will be shared with our investors in accordance with the Capital Markets Legislation.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||